The use of biochemical markers in the diagnosis of pelvic endometriosis
article
OA: closed
CC0
⤵ 86 in-corpus citations
AI-generated summary
CA 125 II, CRP, and SAA were elevated in severe endometriosis patients, while IgM aCL was elevated in all endometriosis patients, suggesting their diagnostic utility.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The aim of this study was to evaluate CA 125 II, C-reactive protein (CRP) and serum amyloid A (SAA) and anticardiolipin antibody (aCL) concentrations for the diagnosis of pelvic endometriosis. The study population consisted of 15 women without endometriosis, as confirmed by laparoscopy (group A), and 35 patients with pelvic endometriosis diagnosed by laparoscopy or laparotomy (group B). Group B patients were divided into those at stages I and II of the disease (BI/II) and those at stages III and IV (BIII/IV). Blood samples were obtained twice during the menstrual cycle: on day 1, 2 or 3 of the cycle and on day 8, 9 or 10 of the cycle. CA 125 II and CRP concentrations were higher in group III/IV patients compared with healthy controls, mainly during the first 3 days of the menstrual cycle; SAA concentrations were also higher in this group of patients compared with healthy controls, but only during the first 3 days of the menstrual cycle. Immunoglobulin (Ig) M aCL concentrations were higher in all patients with endometriosis compared with healthy controls, mainly during the first 3 days of the menstrual cycle. It is concluded that these determinations may contribute to the diagnosis and the indication of treatment for pelvic endometriosis. Determination of CA 125 II concentrations at the beginning of the menstrual cycle may aid the diagnosis of stage III and IV endometriosis. IgM aCL appears to be associated with the presence of all stages of the disease, while SAA values are elevated in severe situations. Measurement of these molecules may therefore provide a valuable tool in the diagnosis and management of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (16)
- CA 125 levels measured in different phases of the menstrual cycle in screening for endometriosis. via openalex
- Cardiolipin antibody levels in endometriosis and systemic lupus erythematosus via openalex
- Clinical Presentation and Diagnosis of Endometriosis via openalex
- ENDOMETRIOSIS via openalex
- Endometriosis : current understanding and management via openalex
- Epidemiology of Endometriosis via openalex
- Etiology and epidemiology of endometriosis via openalex
- Humoral immunological alterations in endometriosis via openalex
- Immunological aspects of endometriosis via openalex
- W2093252833 via openalex
- W2168669957 via openalex
- W2002374079 via openalex
- W2417237384 via openalex
- W3015302834 via openalex
- W2053056059 via openalex
- W42372792 via openalex
Cited by (50)
- The pathogenesis of endometriosis and adenomyosis: insights from single-cell RNA sequencing† 2024
- Endometriosis, Psoriasis, and Psoriatic Arthritis: A Prospective Cohort Study 2022
- Glycemic Index, Glycemic Load, Fiber, and Gluten Intake and Risk of Laparoscopically Confirmed Endometriosis in Premenopausal Women 2022
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- Research progress of CA125 in endometriosis: Teaching an old dog new tricks 2022
- The role of some inflammatory markers, cytokins and tumor markers in diagnosis of endometriosis 2022
- Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool? 2021
- C-reactive Protein for Predicting Early Postoperative Complications in Patients Undergoing Laparoscopic Shaving for Deep Infiltrating Endometriosis 2021
- Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review 2021
- The role of monocyte to high-density lipoprotein cholesterol ratio in prediction of increased systemic inflammation and the risk of cardiovascular disease in endometriosis 2021
- The relationship between C-reactive protein, carbohydrate antigen 125, and hematological parameters to endometriotic nodule localization in pelvis 2020
- Differential expression of progesterone receptor isoforms related to PGR +331g/a polymorphism in endometriosis: A case-control study 2019
- A Prospective Study of Inflammatory Markers and Risk of Endometriosis 2017
- The Level of Ca125 in Preand Postoperative of Endometriosis 2017
- Diagnosis of endometriosis in women with chronic pelvic pain 2016
- Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta‐analysis 2016
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Limited value of pro-inflammatory oxylipins and cytokines as circulating biomarkers in endometriosis – a targeted ‘omics study 2016
- Addition of MCP-1 and MIP-3β to the IL-8 appraisal in peritoneal fluid enhances the probability of identifying women with endometriosis 2015
- Altered Biological Characteristics of Eutopic and Ectopic Endometrium 2014
- Serum YKL-40 levels are altered in endometriosis 2014
- Looking for Celiac Disease in Italian Women with Endometriosis: A Case Control Study 2014
- Can Platelet Indices Be New Biomarkers for Severe Endometriosis? 2014
- Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma 2014
- Association between endometriosis and the interleukin 1A (IL1A) locus 2014
- Copeptin is associated with the severity of endometriosis 2014
- Diagnostic value of the neutrophil-to-lymphocyte ratio and the combination of serum CA-125 for stages III and IV endometriosis 2013
- Understanding the pathogenesis of endometriosis through proteomics: Recent advances and future prospects 2013
- Anatomical causes of female infertility and their management 2013
- Can chemokines be used as biomarkers for endometriosis? A systematic review 2013
- Avaliação dos marcadores de estresse oxidativo em pacientes com endometriose pélvica 2013
- Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study 2012
- C-reactive protein of serum and peritoneal fluid in endometriosis. 2012
- Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis 2012
- Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress 2012
- CA-125 concentration in serum and peritoneal fluid in patients with endometriosis – preliminary results 2012
- Patients With Endometriosis of the Rectosigmoid Have a Higher Percentage of Natural Killer Cells in Peripheral Blood 2012
- Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis 2012
- Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study 2012
- CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results. 2012
- Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study 2012
- Environmental factors and endometriosis 2011
- Immunological Aspects of Endometriosis: An Update 2011
- Inflammation and Endometriosis 2011
- Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2011
- Environmental factors and endometriosis 2011
- A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis 2011
- Role of Eutopic Endometrium in Pelvic Endometriosis 2011
- Avaliação do percentual de células Natural Killer e de auto-anticorpos em sangue periférico de pacientes com endometriose pélvica 2010
- Peripheral biomarkers of endometriosis: a systematic review 2010
Source provenance
- europepmc
- last seen: 2026-06-22T06:15:23.361955+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:10:46.468712+00:00
- unpaywall
- last seen: 2026-06-22T06:34:40.717867+00:00
License: CC0
· commercial use OK